Management of Severe Hyponatremia (Sodium 117 mmol/L)
For a sodium level of 117 mmol/L, you must first determine symptom severity: if the patient has severe neurological symptoms (seizures, altered mental status, coma), immediately administer 3% hypertonic saline with a target correction of 6 mmol/L over 6 hours; if asymptomatic or mildly symptomatic, implement fluid restriction to 1-1.5 L/day and discontinue any contributing medications, particularly diuretics. 1
Initial Assessment
Before initiating treatment, rapidly assess three critical factors:
- Symptom severity: Determine if severe symptoms are present (seizures, coma, altered mental status, cardiorespiratory distress) versus mild symptoms (nausea, headache, weakness) versus asymptomatic 1, 2
- Volume status: Classify as hypovolemic (orthostatic hypotension, dry mucous membranes, poor skin turgor), euvolemic (no edema, normal blood pressure), or hypervolemic (edema, ascites, jugular venous distention) 1
- Acuity: Establish if onset is acute (<48 hours) versus chronic (>48 hours), as chronic hyponatremia carries higher risk of osmotic demyelination with rapid correction 1
Obtain immediate laboratory studies including serum osmolality, urine sodium, urine osmolality, and assess renal, thyroid, and adrenal function 1
Treatment Based on Symptom Severity
Severe Symptomatic Hyponatremia (Medical Emergency)
Administer 3% hypertonic saline immediately with the following protocol 1, 3, 2:
- Give 100 mL boluses of 3% saline over 10 minutes, repeatable up to three times at 10-minute intervals until symptoms improve 1
- Target correction: 6 mmol/L increase over the first 6 hours or until severe symptoms resolve 1
- Critical safety limit: Do not exceed 8 mmol/L correction in 24 hours to prevent osmotic demyelination syndrome 1, 3
- Monitor sodium levels every 2 hours during initial correction 1
- Require ICU admission for continuous monitoring 1
Asymptomatic or Mildly Symptomatic Hyponatremia
Do not use hypertonic saline for patients without severe symptoms 1, 2. Instead:
- Implement fluid restriction to 1-1.5 L/day as first-line treatment 1
- Discontinue diuretics immediately if present 1
- Target slower correction rate of 4-6 mmol/L per day 1
- Monitor sodium levels every 4-6 hours initially, then daily 1
Treatment Based on Volume Status
Hypovolemic Hyponatremia
- Administer isotonic (0.9%) saline for volume repletion 1
- Discontinue any diuretics 1
- Once euvolemic, reassess and adjust treatment based on sodium response 1
Euvolemic Hyponatremia (SIADH)
- Fluid restriction to 1 L/day is the cornerstone of treatment 1
- If no response after 24-48 hours, add oral sodium chloride 100 mEq three times daily 1
- Consider urea or vaptans for resistant cases 1, 2
Hypervolemic Hyponatremia (Cirrhosis, Heart Failure)
- Fluid restriction to 1-1.5 L/day for sodium <125 mmol/L 1
- Discontinue diuretics temporarily 1
- Consider albumin infusion in cirrhotic patients 1
- Avoid hypertonic saline unless life-threatening symptoms present, as it worsens fluid overload 1
Critical Correction Rate Guidelines
The maximum safe correction rate is 8 mmol/L in 24 hours for most patients 1, 3, 2. However, high-risk populations require even slower correction:
High-Risk Patients (Require 4-6 mmol/L per day maximum)
Patients with the following conditions are at increased risk for osmotic demyelination syndrome 1, 3:
- Advanced liver disease or cirrhosis
- Chronic alcoholism
- Severe malnutrition
- Hypokalemia or hypophosphatemia
- Prior history of encephalopathy
For these patients, limit correction to 4-6 mmol/L per day and do not exceed 8 mmol/L in 24 hours 1, 3
Management of Overcorrection
If sodium correction exceeds 8 mmol/L in 24 hours 1:
- Immediately discontinue current fluids and switch to D5W (5% dextrose in water) 1
- Administer desmopressin to slow or reverse the rapid rise in serum sodium 1
- Target relowering to bring total 24-hour correction to no more than 8 mmol/L from baseline 1
- Monitor for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) which typically occur 2-7 days after rapid correction 1
Special Considerations
Neurosurgical Patients
Distinguish between SIADH and cerebral salt wasting (CSW), as treatment differs fundamentally 1:
- CSW requires volume and sodium replacement, not fluid restriction 1
- Consider fludrocortisone for CSW in subarachnoid hemorrhage patients 1
- Never use fluid restriction in patients at risk for vasospasm 1
Cirrhotic Patients
- Hyponatremia at this level increases risk of spontaneous bacterial peritonitis (OR 3.40), hepatorenal syndrome (OR 3.45), and hepatic encephalopathy (OR 2.36) 1
- Use more conservative correction rates (4-6 mmol/L per day) due to higher osmotic demyelination risk 1
- Albumin infusion may improve sodium levels 1
Common Pitfalls to Avoid
- Overly rapid correction exceeding 8 mmol/L in 24 hours causes osmotic demyelination syndrome 1, 3
- Using fluid restriction in cerebral salt wasting worsens outcomes 1
- Inadequate monitoring during active correction 1
- Using hypertonic saline in hypervolemic hyponatremia without life-threatening symptoms 1
- Ignoring high-risk factors that require slower correction rates 1, 3